Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANAB | CGEM | SYRE | ||
| Company | Anaptysbio Inc | Cullinan Therapeutics Inc | Spyre Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 37.51 | 17.88 | 25.08 | ||
| High | 38.05 | 18.17 | 26.35 | ||
| Low | 36.72 | 17.61 | 25.08 | ||
| Last | 37.75 | 18.03 | 25.53 | ||
| Change | +0.46 | +0.17 | +0.77 | ||
| % Change | +1.23% | +0.95% | +3.11% | ||
| Volume | 252,000 | 483,900 | 456,500 | ||
| 20-Day Average Volume | 386,115 | 640,445 | 415,155 | ||
| Previous Close | 37.29 | 17.86 | 24.76 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 34.48 | 17.52 | 26.21 | ||
| 20-Day Raw Stochastic | 66.11% | 49.95% | 26.81% | ||
| 20-Day Relative Strength | 64.11% | 50.01% | 45.02% | ||
| Weighted Alpha | +100.74 | +2.46 | +13.95 | ||
| Today's Opinion | 100% Buy | 8% Sell | 88% Sell | ||
| Previous Opinion | 100% Buy | 8% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 48% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.03% since 08/16/24 | +7.90% since 08/16/24 | -1.96% since 08/16/24 | ||
| Low | 33.14 on 08/19/24 | 16.66 on 08/19/24 | 24.47 on 08/22/24 | ||
| High | 38.16 on 08/22/24 | 18.31 on 08/21/24 | 28.50 on 08/20/24 | ||
| 1-Month | |||||
| %Chg | +2.14% since 07/23/24 | -13.57% since 07/23/24 | -19.79% since 07/23/24 | ||
| Low | 30.81 on 08/05/24 | 15.70 on 08/08/24 | 23.31 on 08/12/24 | ||
| High | 41.31 on 08/14/24 | 21.01 on 07/24/24 | 32.41 on 07/24/24 | ||
| 3-Month | |||||
| %Chg | +51.24% since 05/23/24 | -20.40% since 05/23/24 | -21.88% since 05/23/24 | ||
| Low | 22.26 on 06/20/24 | 15.57 on 06/26/24 | 22.19 on 06/26/24 | ||
| High | 41.31 on 08/14/24 | 24.99 on 05/28/24 | 38.90 on 06/12/24 | ||
| 6-Month | |||||
| %Chg | +45.92% since 02/23/24 | +0.17% since 02/23/24 | +8.27% since 02/23/24 | ||
| Low | 18.49 on 04/25/24 | 14.98 on 03/19/24 | 22.19 on 06/26/24 | ||
| High | 41.31 on 08/14/24 | 30.19 on 05/07/24 | 47.97 on 03/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,031,292 | 1,039,141 | 1,028,425 | ||
| Shares Outstanding, K | 27,319 | 57,634 | 40,283 | ||
| Annual Sales | 17,160,000 | 0 | 890,000 | ||
| Annual Net Income | -163,620,000 | -153,160,000 | -338,790,000 | ||
| Last Quarter Sales | 10,970,000 | 0 | 0 | ||
| Last Quarter Net Income | -46,660,000 | -42,030,000 | -38,840,000 | ||
| 60-Month Beta | -0.25 | -0.12 | 2.93 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.71 on 08/05/24 | -0.75 on 08/08/24 | -0.86 on 08/07/24 | ||
| Latest Earnings Date | 08/05/24 | 08/08/24 | 08/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||